Amycretin

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameAmycretin
Drug Alias NameZenagamtideNNC0487-0111NNC-0487-0111NNC-04870111NNC 04870111 +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionAmylin receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsAmylin ReceptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[33] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/SNovo Nordisk (China)Pharmaceuticals Co LtdNovo Nordisk Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A